Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Treasury Yields Mixed as New Fed Chair Kevin Warsh Takes Office Amid Persistent Bond Volatility M R Maniveni Foods IPO Allotment Date Expected May 27 Check Status Online via BSE Registrar Gold Miners Q1 Earnings Signal Further Upside Potential in Ongoing Bull Run Pakistan to Deploy Paramilitary Force to Secure CopperGold Mining Region Chinese Investors Flock to Dividend Stocks Amid Limited Alternatives Innventure Inc Q1 2026 Earnings NarrowerThanExpected Loss Drives Mixed Market Reaction STNE Q1 2026 Earnings EPS Misses Estimates Stock Slips as Growth Concerns Emerge Lixte Biotechnology Holdings Inc LIXT Q4 2024 Earnings Net Loss of 027 Per Share as Pipeline Progress Continues Cognyte CGNT Q1 2026 Earnings EPS Soars Past Estimates with 126 Surprise ZENA Q4 2025 Earnings Deep Loss Misses Estimates Yet Shares Rally on Strategic Updates Teradata TDC Sheds 147 Testing Support Zone as Sector Headwinds Persist Republic Digital Acquisition Company RDAGU Units Flat at 1055 as SPAC Investors Await Merger Catalyst Crane Harbor Acquisition Corp II Units CRANU Dips 135 Testing Key Support Zone ARQQW Warrants Tumble 10 Testing Key Support at 007 Japans PostWar Intelligence Overhaul 5 Key Points and Strategic Implications Innovative Food Schedules Q1 2026 Earnings Call with Investor QA Session Iran Signals Unwavering Stance on National Rights Geopolitical Tensions May Influence Markets April Jobs Report Preview Market Braces for Signs of Cooling Yet Resilient Labor Market Belden Inc BDC Faces Selling Pressure Tests Key Support Near 102 BCB Bancorp BCBP Edges Lower as Stock Navigates Key Support and Resistance Levels Renatus Tactical Acquisition Corp I RTACU Holds Steady Near Support as Quiet Trading Persists Plum Acquisition Corp IV PLMK Holds Steady at 1063 A SPAC in WaitandSee Mode Yum Brands YUM Edges Lower as Stock Consolidates Between Key Support and Resistance Autolus Therapeutics AUTL Edges Higher Testing Resistance Near 181